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Abstract A disulphide bond was introduced into a single-chain 
Fv form of the anticarbohydrate antibody, Se155-4 by replacing 
Ala-L57 of the light chain and Asp-H106 of the heavy chain with 
cysteines, by site-directed mutagenesis. To maintain the salt- 
bridge from the latter residue to Arg-H98, Tyr-107 was also 
altered to Asp. The resulting ds-scFv was shown to retain full 
antigen-binding activity, by enzyme immunoassay and surface 
plasmon resonance analysis of binding kinetics. Compared with 
the parent scFv, the disulphide bonded form was shown to have 
enhanced thermal stability, by Fourier transform IR spectros- 
copy. The Tm was raised from 60°C to 69°C. The ds-scFv form 
thus combines the stable monomeric form of the disulphide form 
wifh the expression advantages of the scFv. 
K~ v words': Antibody engineering; Fourier transform IR 
swctroscopy; Single-chain Fv; Thermal stability 
1. Introduction 
Fhe antigen-binding site of an antibody is formed from the 
va~'iable domains of its two chains. These associate through 
weak non-covalent interactions and their dimerization is aided 
by the positioning provided by the neighbouring constant do- 
me,ins in the Fab, which associate both non-covalently and 
co,,alently through a disulphide bond. Recombinant forms of 
th, VL-VH heterodimer, or Fv, can be expressed in Escherichia 
co l  from cistronic genes [1], but in many instances these have 
sh,~wn poor VL-VH association. 
['o improve Fv stability, two strategies have been developed. 
In the more common one, the two domains are assembled into 
a ~ingle polypeptide chain through a linker segment ypically 
ar, ,und 15 residues long, forming a single-chain Fv or scFv [1]. 
Tb ~ second approach is to introduce a disulphide bond between 
the two domains, forming a ds-Fv. The positions of the two Cys 
rel,lacements are chosen from the consideration of antibody 
cr, stal structures. The first design of this type by Glockshuber 
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et al. [2] involved residues in the binding-site loops and is, 
therefore, not a general solution. Pastan and coworkers [3-5] 
have recently proposed two general disulphide designs, which 
are pseudo-symmetrically related. 
We have identified another site for introduction of a di- 
sulphide bond in the antibody Se 155~,, an IgG121 anticarbohy- 
drate antibody specific for the Salmonella serotype B polysac- 
charide [6] whose Fab and scFv structures have been deter- 
mined at high resolution [7,8]. The site is intermediate between 
those of the above designs. We have incorporated the di- 
sulphide bond into an scFv version of the antibody and here 
show that this double strategy gives a fully active Fv with 
considerably better stability. 
2. Materials and methods 
2.1. Design of ds-scFv and its gene 
The crystal structure of the Se155 ~, Fab [7] was analysed using the 
Quanta software package (Polygen). The three mutations chosen were 
Ala-L57 to Cys, Asp-H106 to Cys and Tyr-Hl07 to Asp (sequential 
numbering; the Kabat equivalents are L55, H101 and H102). These 
mutations were introduced into clone 3B1, a Se155~, mutant with an 
Ile-H77-Thr substitution that results in higher yields of functional scFv 
in E. coli [9]. This was done by inserting oligonucleotides between 
suitable restriction sites. All DNA manipulations were carried out by 
standard procedures [10]. 
2.2. Expression and purification of antibody fragments 
The scFv and Fab were purified from periplasmic extracts as previ- 
ously described [9,11]. Inclusion bodies containing ds-scFv were har- 
vested from the bacterial cells and the antibody fragment was extracted, 
refolded and oxidized by the procedure of Buchner et al. [12], except 
that the oxidation was carried out at 4°C for 3 days. The products were 
concentrated and the ds-scFv was purified by affinity chromatography 
on an antigen matrix [6]. The monomer forms of both scFv and ds-scFv 
were purified by size-exclusion HPLC on Superdex 75 (Pharmacia 
Biotech). For cleavage of the linker, samples in 0.1 M Tris buffer, pH 
8.0, were incubated with 1:500 subtilisin at 37°C; reactions were 
stopped by addition of 0.1 M phenylmethylsulphonylfluoride in i- 
methylsulphoxide. 
2.3. Immunological nalyses 
Enzyme immunoassays (EIAs) with antigen-coated plates were per- 
formed as previously described [13]. Interaction analysis by surface 
plasmon resonance [14] was carried out with a BIAcore instrument 
(Pharmacia Biosensor, Piscataway, NJ) and the kinetic parameters 
were determined using the BIAevaluation 2.0 software. The antigen 
used was a conjugate of the Salmonella O-chain and bovine serum 
albumin and it was attached to the dextran-gold surface, using the 
amine coupling kit supplied by the manufacturer, in 10 mM Na acetate, 
pH 4.5, at concentrations and contact times that yielded about 200 RU 
of immobilized material. 1 RU corresponds to an immobilized protein 
concentration of 1 pg/mm 2[15]. All measurements were performed at 
ambient emperature in 10 mM HEPES, pH 7.4, 100 mM NaC1, 3.3 
mM EDTA at a flow rate of 5 pl/min and protein concentrations 
between 1.8 and 4.6 pM. Surfaces were regenerated with 10 mM HCI. 
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2.4. Thermal denaturation a alys& by FTIR 
FTIR spectra were acquired on an FTS-40 spectrometer, quipped 
with an MCT detector (BioRad, Cambridge MA) and continually 
purged with dry air (dew point -100°C) from an air-dryer (Balston, 
Haverhill, MA). Samples were exchanged into 2H20 for approximately 
24 h, then placed between two CaF: windows eparated by a 12-#m 
Teflon spacer. The temperature of the sample was regulated by circulat- 
ing water through a thermostatically controlled jacket surrounding 
the CaF2 windows (Harrick, Ossining, NY). Spectra were recorded at 
2 cm -~ resolution and represent the average of 256 scans. 
3. Results 
3.1. Design and production of the ds-scFv 
The positions for mutation to Cys to create an interdomain 
disulphide bond in the Fv were identified within the Se155~ 
structure [7] by visual inspection of residue C~-C~ bond vectors 
and measurement of C~-C~ distances using the Quanta software 
package. The Vc residue was AIa-L57 and the VH residue was 
Asp-H106, and their relationship is shown in Fig. 1. The dis- 
tance between the two Ca atoms was 5.9 A. In many antibodies, 
the residue Asp-H106 is a partner in a highly-conserved salt- 
bridge with Arg-H98. However, previous mutagenesis experi- 
ments [15] had shown that replacement of the next residue, 
Tyr-H107, with Asp gave an Fab with full antigen-binding 
activity. In order to retain an acidic group in this location as 
a potential salt-bridge partner for Arg-H98, this replacement 
was made as well. The three mutations were introduced into an 
scFv gene which had previously been found to give excellent 
expression i to the periplasm of E. coli [9]. However, the mu- 
tant form gave a poorer yield of soluble protein and the ds-scFv 
was, therefore, prepared from the inclusion bodies by denatura- 
tion, refolding and oxidation, by a standard method [11]. The 
overall yield of ds-scFv after purification by affinity chroma- 
tography was 25 mg/1 of culture. 
3.2. Characterization of the ds-scFv 
To demonstrate formation of the interdomain disulphide 
bond, a mild proteolytic leavage was used to sever the linker 
peptide. Preliminary experiments with the parent scFv showed 
that treatment with subtilisin at 1 : 500 for 2 h cleaved the linker 
without degrading the domains (Fig. 2, lanes 2 and 7). When 
ds-scfv molecules were treated in this way, the apparent molec- 
ular weight on SDS-PAGE was little changed (Fig. 2, lane 4) 
but after the product was reduced, fragments of the size of VL 
and VH domains were seen (Fig. 2, lane 9). The disulphide bond 
was, therefore, fully formed in the product. 
The reactivity of the ds-scFv with antigen was first assessed 
by EIA. The parent scFv and the ds-scFv showed very similar 
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Fig. 1. A ribbon diagram of the Se155~ scFv showing the location of the introduced isulphide bond. The light and heavy chains are lighter and 
darker shades of grey, respectively, and the trisaccharide antigen is shown bound in the combining site. The introduced cysteine r sidues at position 
57L and 106H are labeled C57L and C106H, respectively, and the disulphide joining them has been modeled. The side chain of the other mutated 
residue in this construct (Tyr ~ Asp) and the conserved arginine with which it may form a salt bridge are also shown (D 107H and R98H, respectively). 
The large asterisks denote the starting and ending points of the linker connecting the VL and VH domains. This figure is based on Brookhaven Protein 
Data Bank file lmfa and was prepared with InsightlI software from Biosym. 
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Fi~. 2. SDS-PAGE of Se155~ scFv and ds-scFv. Lanes 1~, are samples 
wit+rout reduction; lanes 6 9 are reduced samples. Lanes 1 and 6, scFv 
wig:lout subtilisin treatment; lanes 2 and 7, scFv after 1:500 subtilisin 
tre. tment for 3 h; lanes 3 and 8, ds-scFv without subtilisin treatment; 
lan :s 4 and 9, ds-scFv after 1:500 subtilisin treatment for 3 h; lane 5, 
sta ldards, from bottom, lysozyme, soybean trypsin inhibitor, carbonic 
ant ydrase, ovalbumin, bovine serum albumin. 
aclivity (Fig. 3). More detailed analysis by surface plasmon 
resonance also showed that the kinetics of the antigen-binding 
were essentially unchanged. Although both the scFv and ds-Fv 
existed predominantly in the monomeric form, trace amounts 
of dimer were removed by HPLC prior to surface plasmon 
resonance analysis. Dimerization is frequently seen with scFv 
m~ lecules [16] and has an especially significant effect on the 
bil ding properties of this antibody because of the multivalent 
naure of its carbohydrate antigen. Both the association and 
dissociation phases were fitted well by the BIAevaluation 2.0 
on :-component interaction model. The association rate con- 
stants were determined to be 6.5 x 10 4 and 7.2 x 10 4 M-~s -t for 
scl 'v and ds-scFv, respectively. Both forms displayed rapid and 
ve, y similar dissociation rate constants, 0.11 and 0.15 s -l. The 
K, values of 5.9 x 105 and 4.8 x 105 M l are in good agreement 
wih the value for the scFv from titration microcalorimetry [9]. 
3., Thermal stabilio, of  the ds-scFv 
['he thermal denaturation of the disulphide-bonded molecule 
wa~ compared with that of the parent scFv and Fab by moni- 
toring the amide I' bands in their FTIR spectra, at various 
terlperatures. This band primarily reflects the peptide C--O 
str~'tching vibration which is very sensitive to hydrogen bond- 
in~ and thus protein secondary structure. At temperatures 
beow the thermal transition, the spectra of all three samples 
exidbited an asymmetric band contour with intense maxima 
ne,.r 1635 cm -~ and a weak shoulder near 1680 cm -~ (Fig. 4), 
imicative of predominantly fl-sheet proteins [17,18]. Upon 
he.tting all three samples, a gradual increase in the intensity of 
tht 1635 cm -~ vibration was observed, concomitant with in- 
creases at 1690 and 1620 cm -1. The latter changes have been 
no~ ed previously in thermal denaturation spectra nd are attri- 
buled to protein aggregation [19,20]. The thermal denaturation 
cmves obtained from the changes in intensity at 1620 cm -~ are 
shown in Fig. 5. It is immediately evident hat the ds-scFv has 
co~siderably greater thermal stability than the parent scFv, the 
two Tm values being approximately 60°C and 69°C. The Fab 
fragment of Se155-4 had a Tm of 75°C. 
4. Discussion 
The weak interaction between VL and VH domains is a major 
concern in therapeutic applications of Fvs and Fv immunotox- 
ins. There appears to be a wide range of interaction strengths 
and in one case there was little association at all [21], while in 
another the addition of isopropanol disrupted it extensively 
[22]. Hence, stabilization by scFv or dsFv approaches has been 
extensively pursued. In the experiments presented here, we 
combined these approaches and created a ds-scFv species. This 
construct is superior to the two individual approaches in that 
it combines the merits of both. The linker peptide of the scFv 
element dictates coordinated expression of the two domains, 
and reduces the possibility of homodimer formation during 
refolding and oxidation to form the disulphide bridge. The 
disulphide feature brings enhanced thermal stability and also 
overcomes two disadvantages of scFvs. These are their tend- 
ency to dimerize, which greatly affects biophysical measure- 
ments of their binding properties (C.R. MacKenzie et al., sub- 
mitted for publication) and the equilibrium they presumably 
have between 'open' and 'closed' forms, i.e. with and without 
VL-V~ pairing. The latter phenomenon is probably responsible 
for some Fvs showing lower affinities for antigen than the 
corresponding Fabs. 
The sites chosen for the two cysteines in the present construct 
are close to those in one of the two designs of Pastan and 
coworkers, L43-H105 (Kabat numbering) [3 5]. The construct 
differs in that the L chain Cys at residue 57 (L55 in Kabat 
numbering) is at the end of, rather than before, the CDR L2, 
and the H chain Cys at position 106 (108 in Kabat numbering) 
is positioned four residues earlier in the sequence. The H-chain 
Cys is at a position where an Asp required for a salt-bridge to 
Arg-H98 (94 in Kabat numbering) is often found, so this was 
compensated for by altering the next residue to Asp, a mutation 
previously shown to retain full antigen-binding activity in Fab 
[15]. The position of the disulphide bond is closer to the bind- 
ing-site than in the Jung et al. design [3] but not as close as in 
the design of Glockshuber et al. [2], which involves CDR H3 
residues. The C~-C~ distance between our introduced Cys resi- 
dues varies between 5.76 and 6.12/k among the five different 
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Fig. 3. Indirect EIA showing the binding of Se155-4 scFv and ds-scFv 
to BSA-O-polysaccharide. Open squares, scFv: solid squares, ds-scFv. 
100- 
crystal structures solved for Se1554. The largest distance was 
observed in the scFv and is slightly longer than the longest 
distance spanned by one of the introduced isulphide bonds by 
Jung et al. [3]. Our analysis of possible sites for introduction of 
the disulphide bond did not detect heir L43-H105 site (Kabat 
numbering), as this distance is 7.26 A in Se155-4, due in part 
to differences in the conformation of the light chain fl-strand 
at this point. Their second esign, L106-H44, has a correspond- 
ing distance of 6.19 A the scFv crystal structure and, therefore, 
may also work in Se1554. 
However, our design could not be used in a structure based 
on M603 (the template used by Jung et al. [3]), as the C~-C~ 
distance between corresponding residues is 9.12 A, rather than 
the 6.12 A measured in the scFv of Se155~. Two structural 
factors appear to contribute to this longer distance, viz. the 
conformation of the L2 loop in relation to the rest of the VL 
domain and its possible dependence on H3 loop conformation. 
Although the inner fl-strands in the VL domain which form the 
VL: VH interface are relatively invariant in their fl-strand con- 
formation, the fl-strand leading into the L2 loop of M603 bends 
back and away from the VL: VH interface much more than the 
corresponding strand in Se155-4. This conformation may be a 
structural adaptation to the conformation of the H3 loop in 
M603, to which it is adjacent. In Se155~,, the reverse situation 
holds, with the L2 loop folding closer to the VL : VH interface 
and the H3 loop folding out of the way, in this case, towards 
the central pocket of the combining site. It should also be noted 
that Se155-4 has a 2 light chain rather than the more common 
x light chain, but it is not possible to say whether other, more 
subtle, structural differences between the two light chain types 
are influencing the distance between VL and VH residues. 
The immunological ssays, EIA and surface plasmon reso- 
nance, showed the ds-scFv also was fully active. However, the 
mutations had a deleterious effect on functional expression in 
the periplasm, as is often the case when Cys residues are intro- 
duced into this scFv. Since many scFv and other dsFv species 
are prepared from inclusion bodies, this is not a particular 
problem. 
Introduction of disulphides into proteins has frequently been 
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Fig. 4. FTIR spectra of Se155 ~, ds-scFv in 2H20 as a function of 
temperature. The spectra were recorded at 69, 72, 75, 77, 80 and 83°C 
(top to bottom at the 1635 cm -~ peak). The 2H20 vibrations have been 
subtracted and the spectral baselines were corrected between 1730 and 
1590 cm -1. 
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Fig. 5. Thermal denaturation curves calculated from the FTIR spectra 
for Se155-4 scFv (e), ds-scFv (A) and Fab (e). 
used to enhance their stability. Assessment of the change in 
stability of Fv produced by this means has usually been done 
by non-biophysical methods, such as retention of immunologi- 
cal activity after heating [2,5]. Such experiments showed that 
disulphide bonds enhanced stability as expected, but Tm values 
were not obtained. The FTIR approach used here has the 
advantage of providing a good biophysical measurement of
thermal stabilization, while requiring very little material. The 
scFv denatured at 60°C, a temperature close to the 62°C found 
for an antilysozyme Fv [23] using circular dichroism, but above 
the value for an antidansyl Fv of 52.3°C [24] obtained by 
differential scanning calorimetry. While the Tm of the ds-scFv 
was increased by 9°C, the Fab still had a higher value, 75°C. 
The 15°C difference between the Fv Tm and Fab Tm is the same 
as in the antidansyl antibody [24]. Yasui et al. [23] also observed 
VL-VH dissociation at lower temperatures and found that single 
mutations in the CDRs could dramatically ower the thermal 
stability of their Fv. Since the interaction between VL and VH 
involves residues from the CDR loops, each Fv can be expected 
to have a unique Tm and VL-VH dissociation behaviour. Never- 
theless, the increase in Tm of 9°C for the ds-scFv shows that 
introduction of a disulphide into an scFv should be a valuable 
general route to Fv molecules of enhanced stability. 
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